Login
From:
Alzheimer's News Today
(Uncensored)
subscribe
FDA approves new Kisunla dosing regimen to lower ARIA-E risk
https://alzheimersnewstoday.com/news/fda-approves-new-kisunla-dosing-regimen-lower-aria-e-risk/
links
backlinks
Tagged with:
news
fda approval
donanemab
aria-e
A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug Administration.
Roast topics
Find topics
Find it!
